logo
Collier County shelter can take in cats again July 31, but rescue strain remains high

Collier County shelter can take in cats again July 31, but rescue strain remains high

Yahoo30-07-2025
On July 17, Megan Sorbara posted a photo of a black-and-white tuxedo cat on Facebook, asking for help. She trapped the feral cat the night before and brought him to Collier County Domestic Animal Services, DAS, the next morning to be fixed. Staff turned her away.
"Keep a feral cat in a cage for two weeks? Release him back and never catch him again?" Sorbara wrote in frustration. "This is kitten season, you should be at least continuing TNR (trap-neuter-return), you know try and "fix" the problem so you don't have to shut down intake year after year."
Earlier this month, the county shelter announced it would temporarily halt public feline intake from July 14 through July 30, citing a spike in communicable diseases. But to many in Collier County's animal rescue community, the closure is another sign of a system struggling to keep up with the growing overpopulation and leaving residents with nowhere to turn.
"Despite the best efforts of our staff and volunteers, we're currently dealing with an increase in communicable diseases in cats," DAS Director Meredith McLean said in a press release. "Temporarily pausing intake will help us reduce our feline census, protect the health of animals already in our care, and allow us to focus our resources on urgent, critical cases.'
The shelter saw a 60% increase in cat intake this June compared to the same time last year. DAS only accepted cats that were critically ill, injured, or at-risk during the intake closure.
This isn't the first time the shelter has closed its intake. In August 2024, the county shelter paused intake after multiple cats tested positive for feline panleukopenia, a deadly and highly contagious virus. Each time, local rescues have been left to fill the gap, if they can.
More: Collier County cat rescues face ongoing challenges. A shelter's temporary closure didn't help
What did it mean for rescuers like Megan Sorbara?
Sorbara, who runs Purradise Gardens, a nonprofit cat rescue in Naples, said she had no choice but to pay $260 for a private veterinarian to neuter the cat the county shelter turned away. She relies on the county's shelter TNR program to help control feral cat populations, especially during kitten season.
"It puts more pressure and more expense on these small groups that are not funded like they (DAS) are," Sorbara said. "We don't have staff. We don't have payroll. We don't have a ton of volunteers. We don't have the whole county behind us, and it just puts a lot of pressure on the rest of the groups."
To her, the shutdown wasn't a logistical failure; it was a misuse of public resources.
"Those are county tax dollars that are operating that shelter, and the county (taxpayers) should be able to use it whenever they need it," she said.
"It's not a surprise. It happens every year," Sorbara said, adding that closures like this one aren't new, and the county should be better prepared.
"I do understand they shut down intake to avoid all these animals getting sick," she said, "but at the same time, you know what happens every single year, you know what happens during kitten season, you know what happens during summer. This seems to always happen, so have a plan."
Where to go when the county shelter is closed
While DAS's feline intake was suspended, residents looked to private veterinarians or nonprofit groups. Some of those groups include:
SNIP Collier offers low-cost sterilization for cats and dogs
For the Love of Cats provides TNR support for East Naples and Marco Island
Humane Society Naples has a rescue and adoption center
Residents are encouraged to call ahead, as many local organizations are near or at capacity.
What can you do?
Advocates say lasting change will require a combination of policy changes, community involvement and people stepping up to help.
Here's how you can help:
Adopt or foster
Spay and neuter your pets
Be a responsible pet owner by microchipping, licensing and securing your pets
Support local rescue groups by donating, volunteering and fostering
The county shelter urged residents to consider fostering or adopting animals already in their care. All adoption fees have been waived through Sept. 9.
"We provide all veterinary care, supplies, and support; you just provide the space and love," McLean said. "Even a short-term foster can make a life-saving difference for these animals and help us reduce our feline population."
A crisis that's not going away
As of July 30, the shelter reopened its feline intake. Without meaningful changes to enforcement, funding and community engagement, advocates fear more shutdowns are inevitable.
'The officers won't trap. They said it takes too much time. They really do lean on the other organizations to do that work. And then for what? We don't get anything out of it.'
Her group consists entirely of volunteers and depends solely on donations. "There's only so much room we have,' she said.
Despite more than a decade of efforts, the need hasn't let up. Sorbara's nonprofit has focused its work on an industrial park near Shirley Street and Taylor Road, where volunteers feed over 100 feral cats every night. "Even with all of our trapping efforts and our daily feedings and care, we're still getting kittens," she said, adding that the work costs about $3,000 a month.
While county funding for animal control exists, Sorbara said it's not reaching the boots-on-the-ground groups doing daily fieldwork. "There is funding there, but they're just not using it," Sorbara said.
Mickenzie Hannon is a watchdog reporter for The News-Press and Naples Daily News, covering Collier and Lee counties. Contact her at 239-435-3423 or mhannon@gannett.com.
This article originally appeared on Naples Daily News: Collier County shelter reopens cat intake after pause to fight disease
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available
Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available

Yahoo

time33 minutes ago

  • Yahoo

Daxor Corporation Announces Replay of Nasdaq Closing Bell Ceremony Now Available

The celebration marks a major milestone for the patent-pending, next-generation, rapid, compact, and hand-held Daxor BVA™. Oak Ridge, TN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces that the official replay of its Nasdaq Closing Bell Ceremony is now available. The ceremony, which took place on August 8, 2025, commemorated the FDA 510(k) clearance for its patent-pending, next-generation, rapid, compact, hand-held, lab-based new Daxor BVA™ (Blood Volume Analyzer). You can watch the full replay of the event here: Closing Ceremony. For more information, visit Sign up to receive news on Daxor's innovative technology HERE. About Daxor Corporation Daxor Corporation (NASDAQ: DXR) is tackling healthcare's "multi-billion-dollar silent crisis", the inability to precisely measure blood volume. This often results in suboptimal care, prolonged hospital stays, and increased readmissions for many high-cost medical conditions like heart failure and those requiring ICU care. With 50 years of experience and innovation, Daxor's patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. This empowers clinicians to make individualized treatment decisions that significantly improve patient outcomes and deliver substantial efficiencies in value-based healthcare. Daxor is ISO certified and operates a U.S.-based, 20,000-square-foot state-of-the-art manufacturing facility, positioning the company for accelerated market expansion. Forward-Looking Statements Certain statements in this release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, statements regarding the impact of hiring sales staff and expansion of our distribution channels. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risk associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and additional other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations Contact:Investor Relations Contact:Bret ShapiroCOO – Head of Capital MarketsCOREIR(561)-479-8566-Cellbrets@ in to access your portfolio

Here's Why Halozyme Therapeutics (HALO) Traded Town in Q2
Here's Why Halozyme Therapeutics (HALO) Traded Town in Q2

Yahoo

time33 minutes ago

  • Yahoo

Here's Why Halozyme Therapeutics (HALO) Traded Town in Q2

Meridian Funds, managed by ArrowMark Partners, released its 'Meridian Growth Fund' second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets made a significant rebound during the quarter, increasing 23% from intra-period lows to close at record highs. Against this backdrop, the fund returned 4.10% (net) compared to the Russell 2500 Growth Index's 11.31% return. In addition, please check the fund's top five holdings to know its best picks in 2025. In its second-quarter 2025 investor letter, Meridian Growth Fund highlighted stocks such as Halozyme Therapeutics, Inc. (NASDAQ:HALO). Based in San Diego, California, Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a biopharmaceutical company. The one-month return of Halozyme Therapeutics, Inc. (NASDAQ:HALO) was 11.11%, and its shares gained 12.32% of their value over the last 52 weeks. On August 11, 2025, Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock closed at $62.89 per share, with a market capitalization of $7.356 billion. Meridian Growth Fund stated the following regarding Halozyme Therapeutics, Inc. (NASDAQ:HALO) in its second quarter 2025 investor letter: "Halozyme Therapeutics, Inc. (NASDAQ:HALO) is a leading drug delivery platform company built around its proprietary and commercially validated ENHANZE® technology. This innovative enzyme enables the subcutaneous delivery of biologics and fluids, transforming hours-long intravenous (IV) infusions into quick injections that can be delivered in just minutes. By doing so, ENHANZE can significantly reduce the treatment burden for patients and ease capacity constraints for healthcare providers. Shares of Halozyme declined during the period following news that the Centers for Medicare & Medicaid Services (CMS) may reconsider how it classifies reformulated drugs using ENHANZE. Under the proposed change, such formulations may no longer qualify as 'new drugs,' potentially subjecting them to Medicare price negotiations earlier than previously expected. While the proposal remains under review, we believe ENHANZE continues to offer meaningful advantages—including fewer injection-site reactions and substantial time and cost savings for clinics—making it an important innovation in drug delivery. We slightly reduced our position in the company during the quarter." An image of a research technician wearing lab coat with a syringe full of biopharmaceuticals. Halozyme Therapeutics, Inc. (NASDAQ:HALO) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 31 hedge fund portfolios held Halozyme Therapeutics, Inc. (NASDAQ:HALO) at the end of the first quarter, which was 25 in the previous quarter. In the second quarter of 2025, Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported revenue of $326 million, representing 41% year-over-year increase. While we acknowledge the potential of Halozyme Therapeutics, Inc. (NASDAQ:HALO) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. In another article, we covered Halozyme Therapeutics, Inc. (NASDAQ:HALO) and shared the list of most undervalued biotech stocks to buy. Halozyme Therapeutics, Inc. (NASDAQ:HALO) rose in the previous quarter due to strong earnings and its decision to focus on its core business. In addition, please check out our hedge fund investor letters Q2 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store